# Luis M. Montuenga

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/luis-m-montuenga/

## Facts

| Field | Value |
| --- | --- |
| Citations | 14,595 |
| Field | RNA modifications and cancer |
| h-index | 61 |
| i10-index | 209 |
| Last Known Institution | Clinica Universidad de Navarra |
| OpenAlex ID | https://openalex.org/A5004034328 |
| ORCID iD | 0000-0002-8739-1387 |
| Works | 528 |

## Researcher papers

- [A microRNA DNA methylation signature for human cancer metastasis](https://scholariq.org/papers/a-microrna-dna-methylation-signature-for-human-cancer-metastasis/)
- [Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer](https://scholariq.org/papers/impaired-hla-class-i-antigen-processing-and-presentation-as-a-mechanism-of/)
- [Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges](https://scholariq.org/papers/biomarkers-in-lung-cancer-screening-achievements-promises-and-challenges/)
- [Assessing the Relationship Between Lung Cancer Risk and Emphysema Detected on Low-Dose CT of the Chest](https://scholariq.org/papers/assessing-the-relationship-between-lung-cancer-risk-and-emphysema-detected-on/)
- [A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer](https://scholariq.org/papers/a-prognostic-dna-methylation-signature-for-stage-i-non-small-cell-lung-cancer/)
- [Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression](https://scholariq.org/papers/anaphylatoxin-c5a-creates-a-favorable-microenvironment-for-lung-cancer/)
- [Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines](https://scholariq.org/papers/frequent-brg1-smarca4-inactivating-mutations-in-human-lung-cancer-cell-lines/)
- [Alternative splicing: an emerging topic in molecular and clinical oncology](https://scholariq.org/papers/alternative-splicing-an-emerging-topic-in-molecular-and-clinical-oncology/)
- [A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis](https://scholariq.org/papers/a-combined-pd-1-c5a-blockade-synergistically-protects-against-lung-cancer-growth/)
- [Hypoxia-Inducible Factor-1 (HIF-1) Up-Regulates Adrenomedullin Expression in Human Tumor Cell Lines during Oxygen Deprivation: A Possible Promotion Mechanism of Carcinogenesis](https://scholariq.org/papers/hypoxia-inducible-factor-1-hif-1-up-regulates-adrenomedullin-expression-in-human/)
- [Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors](https://scholariq.org/papers/genome-wide-profiling-of-non-smoking-related-lung-cancer-cells-reveals-common/)

## Researcher topics

- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Researcher university

- [Clinica Universidad de Navarra](https://scholariq.org/institutions/clinica-universidad-de-navarra/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.